Dry Eye Disease Diagnostics Market

Dry Eye Disease Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Dry eye disease is a highly common ophthalmic condition in which the tears do not provide enough lubrication to the eyes. Tears are adequate and unstable, and the instability could lead to inflammation and damage the eyes. Dry eyes make the eyes uncomfortable, and cause stinging and burning sensation in the eyes. Dry eye disease, also known as keratoconjunctivitis sicca, affects around hundred to million people.
Symptoms of dry eyes include stringy mucus, sensitivity towards lights, eye redness, difficulty in wearing contact lenses, difficulty in concentrating for nighttime driving, eye fatigue, and blurred vision. A few other causes of dry eye disease are decreased tear production and increased tear evaporation.
Common causes of dry disease include aging, Sjogren's syndrome, allergic eye disease, rheumatoid arthritis, nerve damage, posterior blepharitis, eyelids problems, eye allergies, and vitamin A deficiency
Dry eye disease occurs in patient with average age of 45 years and is widely prevalent in the geriatric population. Treatment for dry eye disease includes artificial tear drops and ointments, temporary punctual occlusion, lip flow, and other medications.

Increase in prevalence of dry eye disease across the globe and its increasing prevalence in women and geriatric population are major factors propelling the dry eye disease diagnostics market
As per NCBI research in 2018, the overall prevalence of dry eye disease was 54.3% in the age group of 40 years. As per research published by American Journal of Ophthalmology in 2019, the prevalence of dry eye was 7.78% in women, and 2.96% in male population across demographics.
Furthermore, up to 60% to 70% of contact lens wearers experienced dry eye disease and numerous patients that underwent LASIK surgeries also experienced chronic dry eye disease condition. These factors are projected to boost the global market during the forecast period.
Availability of standard diagnostics tests and equipment is also estimated to boost the early management of dry eye disease in next few years. Emerging technologies such as reflective meniscometry, optical coherence tomography, tear osmolarity, and tear film stability analysis provide advancements in the diagnosis of the dry eye condition.

North America dominated the global dry eye disease diagnostics market, followed by Europe. Adoption of technically advanced diagnostics tests for dry eye condition, established healthcare expenditure, rising baby boomer population at risk of suffering from dry eye disease commonly, are a few factors that are likely to propel the dry eye disease diagnostics market during the forecast period. As per National Health and Wellness Survey, 6.8% of the adult population were diagnosed with the dry eye disease condition in 2019, and the prevalence increases with the age and is majorly common in the geriatric population in the region.
Europe is considered to be another prominent market, followed by Asia Pacific. In the U.K., estimated prevalence of the dry eye disease ranges from 5% to 50%. In 2014, an estimated 6.4 million prescriptions were dispensed for dry eye disease, worth of 27 million pounds. Moreover, launch of innovative diagnostic tools for dry eye disease is another factor propelling the market in Europe.

Global Dry Eye Disease Diagnostics Market, by Disease Type

Global Dry Eye Disease Diagnostics Market, by Diagnostics Test

Global Dry Eye Disease Diagnostics Market, by End-user

Global Dry Eye Disease Diagnostics Market, by Region

North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa